The objective of the P/F project program is to grow the number of investigators working in liver disease related research. The primary strategy is to focus on providing pilot funding and mentoring to new investigators, so that they will be able to generate preliminary data for external funding in liver disease research. A secondary strategy is to provide funding to established investigators in other fields, to encourage the established investigator to re-direct their research to liver disease research and to foster collaborations with members of the liver center. Approach: A call for letters of intent is widely disseminated across our institution to reach out to all potential applicants. Letters of intent that fit within the priorities of the Liver Center and that have a reasonable chance of funding are selected for full proposals, which are sent to the External Advisory Board for review. By pre-screening letters of intent, the number of full proposals is limited and all full proposals can be given sufficient time at the Annual Symposium for a presentation followed by questions and feedback from the External Advisory Board and other audience members. Thus the presentation at the Annual Symposium provides an opportunity to mentor new investigators presenting their proposals and offers the External Advisory Board an opportunity to better evaluate the proposals. At the end of the Annual Symposium, the External Advisory Board discusses and scores the applications. Major changes: the two biggest changes for the P/F project program in this application are (1) offering increased opportunity for mentoring of P/F project holders by allowing them to present during the seminars in the Enrichment program; and (2) support by the School of Medicine for a New Investigator

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK048522-21A1
Application #
8970592
Study Section
Special Emphasis Panel (ZDK1-GRB-8 (M2))
Project Start
Project End
Budget Start
2015-12-01
Budget End
2016-11-30
Support Year
21
Fiscal Year
2016
Total Cost
$280,497
Indirect Cost
$110,499
Name
University of Southern California
Department
Type
DUNS #
072933393
City
Los Angeles
State
CA
Country
United States
Zip Code
90032
Nakamura, Brooke N; Glazier, Alison; Kattah, Michael G et al. (2018) A20 regulates canonical wnt-signaling through an interaction with RIPK4. PLoS One 13:e0195893
Guo, Hao; Lee, Changrim; Shah, Mihir et al. (2018) A novel elastin-like polypeptide drug carrier for cyclosporine A improves tear flow in a mouse model of Sjögren's syndrome. J Control Release 292:183-195
Wu, Raymond; Murali, Ramachandran; Kabe, Yasuaki et al. (2018) Baicalein Targets GTPase-Mediated Autophagy to Eliminate Liver Tumor-Initiating Stem Cell-Like Cells Resistant to mTORC1 Inhibition. Hepatology 68:1726-1740
Ogasawara, Noriko; Poposki, Julie A; Klingler, Aiko I et al. (2018) IL-10, TGF-?, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cells. J Allergy Clin Immunol 141:1147-1151.e8
Edman, Maria C; Janga, Srikanth R; Meng, Zhen et al. (2018) Increased Cathepsin S activity associated with decreased protease inhibitory capacity contributes to altered tear proteins in Sjögren's Syndrome patients. Sci Rep 8:11044
Baulies, Anna; Montero, Joan; Matías, Nuria et al. (2018) The 2-oxoglutarate carrier promotes liver cancer by sustaining mitochondrial GSH despite cholesterol loading. Redox Biol 14:164-177
Ju, Yaping; Janga, Srikanth Reddy; Klinngam, Wannita et al. (2018) NOD and NOR mice exhibit comparable development of lacrimal gland secretory dysfunction but NOD mice have more severe autoimmune dacryoadenitis. Exp Eye Res 176:243-251
Peddi, Santosh; Pan, Xiaoli; MacKay, John Andrew (2018) Intracellular Delivery of Rapamycin From FKBP Elastin-Like Polypeptides Is Consistent With Macropinocytosis. Front Pharmacol 9:1184
Zhou, Beiyun; Flodby, Per; Luo, Jiao et al. (2018) Claudin-18-mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis. J Clin Invest 128:970-984
Khanova, Elena; Wu, Raymond; Wang, Wen et al. (2018) Pyroptosis by caspase11/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients. Hepatology 67:1737-1753

Showing the most recent 10 out of 449 publications